褪黑素
结直肠癌
癌症研究
信号转导
激酶
生物
褪黑激素受体
细胞生长
内科学
内分泌学
癌症
医学
组蛋白
转移
调解人
受体
组蛋白H3
下调和上调
污渍
化学
表观遗传学
细胞信号
组织谷氨酰胺转胺酶
细胞生物学
蛋白激酶A
作者
Wanlu Zhang,Lin Yuan,Dawei Yu,Sumeng Qi,Chang Liu,Dongxu Wang,Wenna Wang,Yi Zhang,Sihui Zhang,Liting Lu,Min Wu,Yongye Huang
摘要
ABSTRACT Melatonin has demonstrated antitumor activity in various cancer models, but its effects may depend on the therapeutic dose and cellular environment. We found that melatonin at millimolar concentrations significantly downregulated transglutaminase 2 (TGM2), histone serotonylation (H3K4me3Q5ser), and YTHDF1/m 6 A (N6‐methyladenosine) in a colorectal cancer model. Cross‐interference between TGM2 and YTHDF1 supports a link between these regulatory processes, while molecular docking, pharmacological interventions, and co‐immunoprecipitation experiments suggest the existence of a signaling pathway involving melatonin and the HTR2B receptor. A combined analysis of CHIP‐seq and meRIP‐seq identified salt‐induced kinase 1 (SIK1) as a potential downstream target, and SIK1 interference affected the proliferation and migration of colorectal cancer. Collectively, these findings support a working model in which melatonin‐induced tumor suppression is associated with coordinated changes in TGM2/H3K4me3Q5ser and YTHDF1‐associated m 6 A regulation, with SIK1 emerging as a potential convergent downstream effector.
科研通智能强力驱动
Strongly Powered by AbleSci AI